Vargas MSF, Estrada RC

Idioma: Español
Referencias bibliográficas: 13
Paginas: 455-459
Archivo PDF: 196.95 Kb.

RESUMEN

El virus del papiloma humano es una de las infecciones de trasmisión sexual más comunes, se encuentra asociado con varias enfermedades desde cáncer cervical y anal, hasta verrugas genitales. Sus particularidades inmunológicas le permiten subsistir en algunos pacientes y causar enfermedades malignas. Con la aprobación de la vacuna tetravalente contra el VPH los médicos poseemos una nueva arma en la prevención primaria contra el cáncer cervical, las verrugas genitales y el cáncer anal. Este trabajo revisa los conocimientos actuales sobre esta vacuna y sus indicaciones en medicina general.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Brady, M y otros (2012); HPV Vaccine Recommendation, Committee on infectious diseases; Pediatrics; 129: 602- 605.

2. Diaz, M (2008),Human Papilloma Virus – Prevention and Treatment; Obstetrics and Gynecology Clinics of North America; 35:199–217

3. 3. Douglas. J (2011); Papilloma virus; Goldman’s Cecil Medicine; 2121-2125.

4. Dunne E, Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males, Advisory Committee on Immunization Practices; Morbidity and Mortality Wekly Report. 2011;(50):1705–1708

5. Einstein.M y otros (2009); Clinician’s guide to human papillomavirus immunology: knowns and unknowns; Lancet Infectious Diseases; 9: 347–56.

6. Hager. D (2009); Human Papilloma Virus Infection and Prevention in the Adolescent Population; Journal of Pediatric and Adolescent Gynecology; 22:197-204

7. Kim.J(2010);Targeted human papillomavirus vaccination of men who have sex with men in the USA: a costeffectiveness modelling analysis; Lancet Infectious Diseases;10: 845–52.

8. Knudtson. M, Tiso. S, Phillips. S (2009); Human Papillomavirus and the HPV Vaccine: Are the Benefits Worth the Risks? ; Nursing Clinics of North America; 44: 293–299.

9. Leddy. M, Anderson. B, Gall. S, MD, Schulkin, J(2009); Obstetriciangynecologists and the HPV Vaccine: Practice Patterns, Beliefs, and Knowledge, Journal of Pediatric and Adolescent Gynecology; 22: 239-246

10. Markowitz L, Dunne E, Saraiya M(2007); Centers for Disease Control and Prevention. Quadrivalent human papillomavirus vaccine. Recommendations of the Advisory Committee on Immunization Practices; Morbidity and Mortality Wekly Report ; 56:1-24.

11. Vaughn. J, Miller, R (2011)Update on Immunizations in Adults, American Family Physician.;84:1015-1020.

12. Waxman. A, Zsemlye. M (2008);Preventing Cervical Cancer: The Pap Test and the HPV Vaccine; Medical Clinics of North America; 92:1059– 1082

13. Wheeler. C.M, (2008); Natural History of Human Papillomavirus Infections, Cytologic and Histologic Abnormalities, and Cancer. Obstetrics and Gynecology Clinics of North America; 35 519–536